ANAVEX LIFE SCIENCES CORP.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $6.3M | $9.2M |
| FY2017 | — | $25.9M | $27.4M |
| FY2018 | — | $22.3M | $22.9M |
| FY2019 | — | $20.3M | $22.2M |
| FY2020 | — | $27.2M | $29.2M |
| FY2021 | — | $150.8M | $152.1M |
| FY2022 | — | $142.5M | $149.2M |
| FY2023 | — | $141.9M | $151.0M |
| FY2024 | — | $120.3M | $132.2M |
| FY2025 | — | $94.9M | $102.6M |